Nagoya University researchers and colleagues in Japan have uncovered a molecular pathway that enhances chemotherapy resistance in some pancreatic cancer patients. Targeting an RNA to interrupt its activity could improve patient response to therapy and increase their overall survival.
“Pancreatic cancer is one of the most aggressive human malignancies, with an overall median survival that is less than five months,” says cancer biologist Yutaka Kondo of Nagoya University Graduate School of Medicine. Read more . . .